Back to Articles
45262026 Q3PrimeJGAAP

RIKEN VITAMIN (4526) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥72.5B (-0.5% year on year) and operating income ¥5.7B (-24.2%). The segment drivers and cash flow follow.

RIKEN VITAMIN CO.,LTD.

Foods/Foods


Quick View

MetricCurrent PeriodSame Period Previous YearYoY
Revenue¥725.0B¥728.5B−0.5%
Operating Income¥57.2B¥75.4B−24.2%
Ordinary Income¥64.0B¥82.4B−22.3%
Net Income¥59.5B¥58.4B+2.0%
ROE7.3%7.4%-

Executive Summary

For the cumulative Q3 period of the fiscal year ending March 2026, revenue declined and operating income decreased, with weakening core earning power being the key issue. Revenue was ¥725.0B (-0.5% year on year), Operating Income was ¥57.2B (-24.2%), Ordinary Income was ¥64.0B (-22.3%), and Net Income was ¥59.5B (+2.0%). The increase in Net Income was attributable primarily to extraordinary income, including a gain on the sale of investment securities of ¥20.6B, contrasting with the declines at the operating and ordinary income levels.

Factors Affecting Financial Performance

【Revenue】Revenue was ¥725.0B, down 0.5% year on year. While the Domestic Food Business, accounting for 69.5% of revenue, increased revenue to ¥503.5B (+1.7%), and the Domestic Chemicals and Other Business increased revenue to ¥64.8B (+7.9%), the Overseas Business declined sharply to ¥156.7B (-9.6%), becoming the primary factor behind the consolidated revenue decline.

【Profitability】Operating Income was ¥57.2B (-24.2%), and the Operating Income Margin was 7.9%, down approximately 2.5pt from approximately 10.4% in the same period of the previous year. Despite higher revenue, segment profit in the Domestic Food Business declined 10.2%. In the Overseas Business, segment results fell from profit of ¥11.4B to a loss of ¥0.97B, becoming the largest factor behind the decline in consolidated Operating Income. Ordinary Income also declined to ¥64.0B (-22.3%), with non-operating income, centered on dividend income of ¥6.4B, insufficient to offset the decline in Operating Income. Meanwhile, Net Income was supported by extraordinary income of ¥23.1B, primarily comprising a gain on the sale of investment securities of ¥20.6B, and increased to ¥59.5B (+2.0%). With revenue slightly declining while Operating Income fell significantly, the conclusion is that the company experienced lower revenue and lower profit, with the increase in Net Income attributable to temporary factors.

Segment Analysis

The Domestic Food Business reported revenue of ¥503.5B (+1.7% year on year), segment profit of ¥50.8B (-10.2%), and a profit margin of 10.1%. Although it is the core business, accounting for approximately 90% of total consolidated segment profit, it shifted to higher revenue but lower profit. The Domestic Chemicals and Other Business reported revenue of ¥64.8B (+7.9%), segment profit of ¥6.8B (-2.5%), and a profit margin of 10.4%. The Overseas Business reported revenue of ¥156.7B (-9.6%) and a segment loss of ¥0.97B, compared with profit of ¥11.4B in the same period of the previous year, resulting in a loss-making position and a negative profit margin of 0.6%. While the two domestic businesses maintained profit margins in the 10% range, deteriorating profitability in the Overseas Business was the primary factor behind the decline in the consolidated profit margin. In addition, from Q1, the company changed its measurement method by allocating a portion of company-wide expenses to the Overseas Business; the comparative figures for the same period of the previous year have been reclassified on the same basis.

Key Financial Indicators

【Profitability】Operating Income Margin was 7.9% (-2.5pt year on year), Ordinary Income Margin was 8.8% (-2.5pt), and Net Income Margin was 8.2% (+0.2pt). The improvement in the Net Income Margin was attributable to extraordinary income, while earning power at the ordinary income level declined. ROE was 7.3%.【Cash Flow Quality】DSO was 91 days, DIO was 124 days, and CCC was 166 days, indicating a buildup of working capital. Trade receivables of ¥241.6B and inventories of ¥100.1B, totaling ¥341.7B, substantially exceeded trade payables of ¥88.1B.【Investment Efficiency】Investment securities of ¥153.3B accounted for 13.1% of total assets, and a gain on the sale of investment securities of ¥20.6B boosted Net Income for the current period.【Financial Soundness】With an Equity Ratio of 70.2%, a Current Ratio of 321.2%, and a D/E Ratio of 0.42x, the company has a conservative financial structure and strong resilience to short-term liquidity pressures and interest expenses.

Cash Flow Analysis

As the company does not disclose a statement of cash flows, funding trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥176.8B, down ¥45.2B from ¥222.98B in the same period of the previous year. Trade receivables increased to ¥241.6B from ¥207.3B in the same period of the previous year, while inventories increased to ¥100.1B from ¥85.9B. The buildup of working capital is viewed as one factor behind the decline in cash and deposits. Meanwhile, investment securities increased year on year to ¥153.3B, indicating that the balance was maintained despite the recognition of gains on sales of investment securities. Interest-bearing debt totaled ¥81.8B, comprising short-term borrowings of ¥29.8B and long-term borrowings of ¥52.0B, down from ¥99.1B in the same period of the previous year, indicating progress in debt repayment. Net assets increased to ¥819.7B, supported by the accumulation of retained earnings and an increase in foreign currency translation adjustments.

Earnings Quality

Net Income was ¥59.5B compared with Ordinary Income of ¥64.0B, representing a divergence of only negative 7.1%. However, Profit Before Tax was ¥84.6B, exceeding Ordinary Income by ¥20.6B. This difference resulted from the net amount of extraordinary income of ¥23.1B, primarily comprising a gain on the sale of investment securities of ¥20.6B, and extraordinary losses of ¥2.5B. Accordingly, the year-on-year increase of 2.0% in Net Income does not indicate an improvement in recurring earning power; rather, it was heavily influenced by the temporary factor of asset sales. Non-operating income of ¥9.8B was modest at 1.3% of revenue, but was centered on dividend income of ¥6.4B, indicating a certain degree of reliance on stable income from investment securities. As Ordinary Income and Operating Income continued to decline while only Net Income increased, this situation requires monitoring from an earnings-quality perspective.

Earnings Forecast and Guidance

The full-year company forecasts are revenue of ¥960.0B (+0.4% year on year), Operating Income of ¥62.0B (-28.9%), and Ordinary Income of ¥70.0B (-25.7%). The 9-month cumulative progress rate was 75.5% for revenue, a standard level, while it was 92.2% for Operating Income, 91.5% for Ordinary Income, and 91.5% for Net Income, all substantially above the standard level of 75%. This reflects the fact that the full-year forecasts themselves are conservative plans incorporating substantial declines in Operating Income and Ordinary Income; therefore, the high progress rates cannot simply be assessed as indicating upside potential. If the plan is achieved, Q4 Operating Income is calculated to be approximately ¥4.8B, making profitability improvement in the Overseas Business the key to achieving the plan.

Shareholder Returns

The Q2 dividend was ¥55.00 per share, and the full-year forecast dividend is ¥110.00 annually. Based on forecast EPS of ¥219.84, the Payout Ratio is approximately 50.0%. The plan appears to assume equal interim and year-end dividends. On the basis of 9-month cumulative Net Income, the Payout Ratio is only approximately 28.4%; however, because Net Income was supported by gains on the sale of investment securities, the recovery potential of Operating Income and Ordinary Income should be emphasized when assessing the sustainability of the dividend funding. The financial base, including an Equity Ratio of 70.2% and cash and deposits of ¥176.8B, supports the company’s capacity to pay dividends.

Risk Factors

  1. Deterioration in Overseas Business profitability: The Overseas Business reported revenue of ¥156.7B (-9.6% year on year), while segment results fell from profit of ¥11.4B in the same period of the previous year to a loss of ¥0.97B. Continued deterioration in overseas demand or the ability to absorb local costs could impede a recovery in consolidated profit.

  2. Cost pass-through capacity in the Domestic Food Business: While revenue in the Domestic Food Business increased 1.7%, segment profit declined 10.2%. The business may not have been able to sufficiently pass increases in raw material, logistics, and other costs on to prices.

  3. Working capital buildup: DSO of 91 days, DIO of 124 days, and CCC of 166 days all exceed generally sound levels. Continued funds being tied up in trade receivables and inventory could lead to inventory valuation risk and lower capital efficiency if demand slows.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (food_beverage)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Income Margin7.9%5.0% (4.5%–7.6%)+2.8pt
Net Income Margin8.2%3.9% (2.8%–6.7%)+4.3pt

The company’s profitability exceeds the industry median, with both its Operating Income Margin and Net Income Margin at relatively high levels within the industry.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (YoY)−0.5%3.4% (-0.4%–4.7%)−3.9pt

The Revenue Growth Rate is below the industry median, indicating that top-line growth is relatively weak within the industry.

※Source: Company compilation

Key Points from the Earnings Results

  1. Core earning power was weak, with Operating Income of ¥57.2B (-24.2% year on year). Margin recovery in the Domestic Food Business and a return to profitability in the Overseas Business will be the key areas of focus going forward.

  2. Net Income of ¥59.5B (+2.0%) benefited substantially from extraordinary income attributable to gains on the sale of investment securities. Given the divergence from Ordinary Income of ¥64.0B (-22.3%), the quality of earnings requires careful assessment.

  3. With an Equity Ratio of 70.2%, a Current Ratio of 321.2%, and a D/E Ratio of 0.42x, the company has a conservative financial base and sufficient financial capacity to improve working capital and address its business structure.

Theoretical Share Price (Reference Value)

ScenarioTheoretical Share Price
bear¥2,628
base¥2,706
bull¥2,714
Calculation AssumptionValue
Book Value Per Share (BPS)¥2,792
Adjusted Forecast EPS¥241.8
Cost of Equity r9.77% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 1.00%)
Persistence Factor of Residual Income ω / Explicit Forecast Period0.62 / 5 years
Assumed Payout Ratio50.0%
Forecast EPS Confidence Adjustment×1.100 (based on progress ahead of the full-year forecast)
implied PBR / PER0.97x / 11.2x

Sensitivity: ¥2,633–¥2,783 for ±1% in the Cost of Equity, and ¥2,704–¥2,708 for ±0.1 in ω.

Notes:

  • Because the progress of Net Income against the full-year forecast is 92%, exceeding the standard level of 75%, forecast EPS has been adjusted upward within a maximum range of +10% (because companies whose progress is ahead of plan tend to exceed their forecasts; the adjustment may be excessive for businesses with strong seasonality).
  • Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
  • Net assets as of the quarter-end have been used; there is a timing gap between these figures and the full-year forecast.
  • Because Net Assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest-rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)


This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---


AI Financial Analysis

Executive Summary

FY2026 Q3 performance was operationally weak despite a modest increase in reported net income, as a securities-sale gain offset a material decline in core earnings. Cumulative revenue for the first nine months decreased 0.5% year on year to ¥72.50bn. Operating income declined 24.2% to ¥5.72bn, substantially underperforming the broadly flat top line. Ordinary income also fell 22.3% to ¥6.40bn. Gross profit decreased 6.1% to ¥22.84bn, while SG&A increased 2.0% to ¥17.12bn. Consequently, the gross margin compressed by 190bp to 31.5% from 33.4%. The operating margin compressed by 250bp to 7.9% from 10.4%. Net income attributable to owners nevertheless rose 2.0% to ¥5.95bn, lifting the reported net margin by 20bp to 8.2%. This divergence reflects ¥2.31bn of extraordinary income, principally a ¥2.07bn gain on sale of investment securities, versus ¥0.83bn of extraordinary income a year earlier. Excluding extraordinary gains and losses, profitability deteriorated materially, with profit before tax up only 4.9% despite the sharp operating-income decline. Domestic food remained the core business, generating ¥50.82bn of revenue and ¥5.08bn of segment profit, but its segment margin declined. Overseas operations were the principal drag, moving from a ¥1.14bn segment profit to a ¥0.10bn loss as revenue declined 9.6%. The balance sheet remains conservatively financed, with a 321.2% current ratio, 70.2% capital adequacy ratio, and only 0.42x debt-to-equity. However, elevated receivable days, inventory days, and the 166-day cash-conversion cycle require attention because they can constrain cash conversion even in a liquid balance-sheet position. Q3 operating income has already reached 92.2% of the full-year forecast, 17.2 percentage points above the standard 75% progress rate, whereas the full-year plan still implies a weak fourth-quarter operating result. The key forward issue is whether overseas profitability and domestic food margins recover sufficiently to prevent the securities gain from masking a weaker underlying earnings trajectory.

Profitability Analysis

Annualized DuPont ROE is 9.7%, comprising an 8.2% net profit margin, 0.828x asset turnover, and 1.42x financial leverage. The return profile is therefore supported primarily by a solid reported net margin and conservative-but-positive leverage rather than unusually high asset utilization. The most material deterioration is in operating profitability: operating margin fell 250bp year on year to 7.9%, while gross margin fell 190bp to 31.5%. SG&A rose 2.0% while revenue fell 0.5%, evidencing negative operating leverage and amplifying the gross-profit decline. The reported 8.2% net margin is flattered by the ¥2.07bn gain on sale of investment securities; this item alone represented 2.8% of nine-month revenue. The five-factor analysis shows a 0.703 tax burden, which is broadly normal, and an interest burden above 1.0x because profit before tax benefited from non-operating and extraordinary gains rather than indicating debt stress. Interest coverage is very strong at 65.7x, and interest expense was only ¥0.87bn. Domestic food, the core business by segment profit contribution, recorded revenue growth of 1.7% to ¥50.35bn but segment profit fell 10.2% to ¥5.08bn; its margin declined to 10.1% from 11.4%. Domestic chemical products and other operations grew revenue 7.9% to ¥6.48bn, but segment profit edged down 2.5% to ¥0.68bn and margin declined to 10.4% from 11.5%. Overseas revenue fell 9.6% to ¥15.67bn and its margin deteriorated from 6.6% to negative 0.6%, producing a ¥0.97bn segment loss. The sustainability of reported ROE depends on restoring underlying operating margins, because the securities-sale gain is non-recurring.

Growth Assessment

Revenue was essentially flat, with a 0.5% decline in the nine-month period, indicating limited consolidated growth momentum. Domestic food revenue growth of 1.7% provided partial resilience, while domestic chemical products and other operations expanded 7.9%. These gains were more than offset by a 9.6% decline in overseas revenue. The overseas reversal from ¥1.14bn of segment profit to a ¥0.10bn loss is particularly important because it accounted for most of the consolidated operating-income decline. The full-year sales forecast is ¥96.00bn, and nine-month sales progress is 75.5%, broadly consistent with the normal 75% seasonal benchmark. Operating-income progress is 92.2% against the ¥6.20bn full-year plan, well above the normal 75% benchmark. Ordinary-income progress is 91.5% against the ¥7.00bn forecast, also ahead of the normal pace. Profit attributable to owners has reached 91.5% of the ¥6.50bn full-year forecast, but this progress is materially supported by the investment-security disposal gain. The full-year forecast calls for revenue growth of 0.4% but operating-income decline of 28.9%, consistent with persistent margin pressure rather than a near-term earnings rebound. The Q4 implication of the operating-income forecast is approximately ¥0.48bn, compared with ¥5.72bn accumulated through Q3, making quarterly execution and any year-end cost or inventory adjustments important to monitor.

Financial Health

Liquidity is strong: current assets of ¥67.53bn exceed current liabilities of ¥21.02bn, resulting in a 321.2% current ratio and ¥46.50bn of working capital. The 273.6% quick ratio indicates that liquidity is not dependent on inventory realization. Cash and deposits of ¥17.68bn cover short-term loans of ¥2.98bn by 5.93x. Interest-bearing debt totals ¥8.18bn, equivalent to 9.1% of capital and a conservative 0.42x debt-to-equity ratio. Short-term loans represent 36.5% of interest-bearing debt, while current assets substantially exceed both current liabilities and short-term debt; there is no apparent maturity mismatch. Interest coverage of 65.7x further supports a low refinancing-risk assessment. Total equity increased ¥2.77bn year on year to ¥81.97bn, and the capital adequacy ratio remained stable at 70.2%. Treasury stock increased in absolute balance by ¥1.45bn to negative ¥3.40bn, a 74.3% increase in the contra-equity balance; this represents a meaningful capital-allocation movement and reduces equity available as a loss buffer, although the overall equity base remains substantial. Asset retirement obligations increased from ¥0.61bn to ¥2.15bn, up ¥1.54bn or 251.6%, and equal to 6.2% of total liabilities. The higher asset-retirement-obligation burden is material because it raises long-dated decommissioning and restoration commitments, although it is not a near-term liquidity threat given the company's cash and working-capital position. Investment securities represent 13.1% of total assets at ¥15.33bn, and the realized gain on their sale demonstrates that non-core financial assets can have a meaningful effect on reported earnings.

Notable B/S Changes

Treasury stock: negative balance increased by ¥1.45bn to negative ¥3.40bn (+74.3% in absolute balance) - material contra-equity increase; assess alongside dividends using total return rather than dividend payout alone. Asset retirement obligations: +¥1.54bn to ¥2.15bn (+251.6%) - long-term restoration and decommissioning obligations increased materially and now equal 6.2% of total liabilities. Accounts receivable: +¥3.43bn to ¥24.16bn (+16.5%) - contributes to the elevated 91-day DSO and increases working-capital funding needs. Finished goods: +¥1.50bn to ¥10.01bn (+16.6%) - consistent with the elevated 124 inventory days and raises inventory-efficiency and valuation-monitoring requirements. Property, plant and equipment: +¥1.50bn to ¥27.03bn (+5.9%) - continued fixed-asset investment, with buildings increasing ¥1.76bn to ¥13.77bn. Total equity: +¥2.77bn to ¥81.97bn (+3.5%) - retained earnings and positive comprehensive income reinforced an already strong capital base.

Cash Flow Quality

Working-capital indicators warrant close scrutiny. DSO is 91 days, above the 60-day alert threshold, indicating a relatively long collection cycle. Inventory days are 124 days, above the 90-day alert threshold and high for processed-food benchmarks. The cash-conversion cycle is 166 days, exceeding the 120-day alert threshold and indicating that a considerable amount of capital is tied up between procurement, production, inventory holding, and customer collection. Accounts receivable increased ¥3.43bn year on year to ¥24.16bn, while finished goods increased ¥1.50bn to ¥10.01bn. Raw materials rose ¥0.33bn to ¥6.36bn and work in process rose ¥1.07bn to ¥6.06bn, reinforcing the increase in operating working-capital intensity. Trade payables increased ¥1.39bn to ¥8.81bn and electronically recorded obligations increased ¥0.18bn to ¥0.66bn, providing some supplier-financing offset, but not enough to eliminate the long conversion cycle. The combination of high DSO, high inventory days, and declining operating profit is a potential earnings-quality concern because future cash conversion depends on timely collection and inventory sell-through. For a food manufacturer, high inventory duration also elevates risks around obsolescence, commodity-cost exposure, and the need for inventory valuation adjustments.

Dividend Sustainability

The interim dividend is ¥55 per share. Based on nine-month net income attributable to owners of ¥5.95bn, the interim payment corresponds to a calculated 28.4% payout ratio. The full-year dividend forecast is ¥110 per share, equal to an implied dividend payout ratio of approximately 50.0% against forecast EPS of ¥219.84. This is below the 60% sustainability benchmark and appears consistent with the company's substantial retained earnings of ¥67.48bn and conservative leverage. However, the quality of earnings available to support shareholder distributions is weaker than the headline net-income result suggests because ¥2.07bn of securities-sale gains supported the nine-month result. The increase in treasury stock by ¥1.45bn is a material additional capital-allocation item; when dividends and any repurchase-related treasury-stock increase are assessed together, the appropriate measure is the total return ratio rather than the dividend payout ratio alone. The strong liquidity position provides financial flexibility, while the elevated working-capital cycle remains the central factor to monitor for the cash backing of distributions.

Risk Assessment

Business risks include Overseas business risk: overseas revenue declined 9.6% to ¥15.67bn and the segment shifted from a ¥1.14bn profit to a ¥0.10bn loss. A sustained overseas loss would continue to dilute consolidated margins., Food-manufacturing cost and pricing risk: consolidated gross margin compressed 190bp to 31.5%, indicating exposure to input, production, packaging, energy, logistics, or pricing pressures., Working-capital and inventory risk: 124 inventory days and a 166-day cash-conversion cycle are high for food-related operations and raise the risk of slow-moving inventory, valuation pressure, and cash tied up in operations., Customer-collection risk: DSO of 91 days is above the 60-day alert threshold and makes the timing of receivable collection important for liquidity conversion., Food-industry risk: food safety events, product recalls, commodity-supply disruptions, and changing consumer preferences can affect volumes, costs, and brand value..

Financial risks include Reported profit quality risk: net income rose 2.0% while operating income fell 24.2%, primarily because a ¥2.07bn gain on sale of investment securities lifted extraordinary income., Asset-retirement-obligation risk: asset retirement obligations rose ¥1.54bn to ¥2.15bn and account for 6.2% of total liabilities, increasing long-term restoration obligations., Market-value exposure: investment securities total ¥15.33bn, or 13.1% of total assets, leaving comprehensive income and equity exposed to valuation movements., Capital-allocation risk: the 74.3% increase in the treasury-stock balance is significant relative to the period's reported earnings and should be assessed alongside dividend commitments..

Key concerns include Highest priority: recovery of overseas profitability and the drivers behind the segment's ¥1.23bn year-on-year profit deterioration., High priority: restoration of gross and operating margins, as SG&A grew while consolidated revenue declined., High priority: conversion of receivables and inventories into cash, given the 91-day DSO, 124-day inventory days, and 166-day cash-conversion cycle., Moderate priority: the extent to which future earnings can replace non-recurring securities-sale gains., Moderate priority: the scale, timing, and funding implications of the increased asset-retirement obligations..

Investment Implications

Key takeaways include Underlying earnings weakened materially: operating income fell 24.2% and operating margin declined 250bp to 7.9%., The 2.0% increase in net income was not representative of core operating momentum because it was supported by a ¥2.07bn gain on sale of investment securities., Domestic food is the earnings anchor, but its segment margin declined 130bp despite 1.7% revenue growth., The overseas business is the main operational issue after moving into a segment loss., Balance-sheet liquidity and leverage metrics remain strong, providing capacity to absorb operational volatility..

Metrics to watch include Overseas segment revenue, segment profit, and margin recovery, Domestic food gross-margin and segment-margin trends, Consolidated operating margin versus the 7.9% nine-month level, DSO, inventory days, and cash-conversion-cycle improvement from 91, 124, and 166 days, respectively, Frequency and magnitude of gains from investment-security sales, Treasury-stock movements and total return ratio, Asset retirement obligations relative to total liabilities.

Regarding relative positioning, The company exhibits a stronger-than-average balance-sheet profile for a food manufacturer, with very high liquidity, low leverage, and strong interest coverage. Its 31.5% gross margin remains within the healthy 25-40% food-industry range, but the 7.9% operating margin is below the 8-15% good-profitability range and has deteriorated sharply. The principal relative weakness is working-capital efficiency, as inventory duration and the cash-conversion cycle exceed food-industry warning thresholds.